Your browser doesn't support javascript.
loading
Show: 20 | 50 | 100
Results 1 - 3 de 3
Filter
Add more filters








Database
Language
Publication year range
1.
EBioMedicine ; 46: 499-511, 2019 Aug.
Article in English | MEDLINE | ID: mdl-31327695

ABSTRACT

BACKGROUND: Fibromyalgia is a complex, relatively unknown disease characterised by chronic, widespread musculoskeletal pain. The gut-brain axis connects the gut microbiome with the brain through the enteric nervous system (ENS); its disruption has been associated with psychiatric and gastrointestinal disorders. To gain an insight into the pathogenesis of fibromyalgia and identify diagnostic biomarkers, we combined different omics techniques to analyse microbiome and serum composition. METHODS: We collected faeces and blood samples to study the microbiome, the serum metabolome and circulating cytokines and miRNAs from a cohort of 105 fibromyalgia patients and 54 age- and environment-matched healthy individuals. We sequenced the V3 and V4 regions of the 16S rDNA gene from faeces samples. UPLC-MS metabolomics and custom multiplex cytokine and miRNA analysis (FirePlex™ technology) were used to examine sera samples. Finally, we combined the different data types to search for potential biomarkers. RESULTS: We found that the diversity of bacteria is reduced in fibromyalgia patients. The abundance of the Bifidobacterium and Eubacterium genera (bacteria participating in the metabolism of neurotransmitters in the host) in these patients was significantly reduced. The serum metabolome analysis revealed altered levels of glutamate and serine, suggesting changes in neurotransmitter metabolism. The combined serum metabolomics and gut microbiome datasets showed a certain degree of correlation, reflecting the effect of the microbiome on metabolic activity. We also examined the microbiome and serum metabolites, cytokines and miRNAs as potential sources of molecular biomarkers of fibromyalgia. CONCLUSIONS: Our results show that the microbiome analysis provides more significant biomarkers than the other techniques employed in the work. Gut microbiome analysis combined with serum metabolomics can shed new light onto the pathogenesis of fibromyalgia. We provide a list of bacteria whose abundance changes in this disease and propose several molecules as potential biomarkers that can be used to evaluate the current diagnostic criteria.


Subject(s)
Fibromyalgia/etiology , Fibromyalgia/metabolism , Gastrointestinal Microbiome , Glutamates/metabolism , Metabolome , Metabolomics , Adult , Aged , Biomarkers , Chromatography, High Pressure Liquid , Computational Biology/methods , Cytokines/metabolism , Female , Humans , Male , Metabolomics/methods , Metagenome , Metagenomics/methods , Middle Aged , RNA, Ribosomal, 16S/genetics , ROC Curve , Tandem Mass Spectrometry
2.
Nat Commun ; 9(1): 5318, 2018 12 14.
Article in English | MEDLINE | ID: mdl-30552320

ABSTRACT

Oocyte-specific miRNA function remains unclear in mice and worms because loss of Dgcr8 and Dicer from mouse and worm oocytes, respectively, does not yield oogenic defects. These data lead to several models: (a) miRNAs are not generated in oocytes; (b) miRNAs are generated but do not perform an oogenic function; (c) functional oocyte miRNAs are generated in a manner independent of these enzymes. Here, we test these models using a combination of genomic, expression and functional analyses on the C. elegans germline. We identify a repertoire of at least twenty-three miRNAs that accumulate in four spatial domains in oocytes. Genetic tests demonstrate that oocyte-expressed miRNAs regulate key oogenic processes within their respective expression domains. Unexpectedly, we find that over half of the oocyte-expressed miRNAs are generated through an unknown Drosha independent mechanism. Thus, a functional miRNA repertoire generated via Drosha dependent and independent pathways regulates C. elegans oocyte development.


Subject(s)
Caenorhabditis elegans/genetics , Genomics , MicroRNAs/genetics , MicroRNAs/metabolism , Oocytes/growth & development , Oocytes/metabolism , Oogenesis/physiology , Animals , Caenorhabditis elegans/embryology , Caenorhabditis elegans/growth & development , Caenorhabditis elegans Proteins/genetics , Caenorhabditis elegans Proteins/metabolism , Fertility/genetics , Fertility/physiology , Germ Cells , In Situ Hybridization , Meiosis/physiology , Oocytes/cytology , RNA Interference , Ribonuclease III/genetics , Ribonuclease III/metabolism
3.
J Forensic Sci ; 62(2): 308-316, 2017 Mar.
Article in English | MEDLINE | ID: mdl-27907229

ABSTRACT

In forensic DNA casework, the interpretation of an evidentiary profile may be dependent upon the assumption on the number of individuals from whom the evidence arose. Three methods of inferring the number of contributors-NOCIt, maximum likelihood estimator, and maximum allele count, were evaluated using 100 test samples consisting of one to five contributors and 0.5-0.016 ng template DNA amplified with Identifiler® Plus and PowerPlex® 16 HS. Results indicate that NOCIt was the most accurate method of the three, requiring 0.07 ng template DNA from any one contributor to consistently estimate the true number of contributors. Additionally, NOCIt returned repeatable results for 91% of samples analyzed in quintuplicate, while 50 single-source standards proved sufficient to calibrate the software. The data indicate that computational methods that employ a quantitative, probabilistic approach provide improved accuracy and additional pertinent information such as the uncertainty associated with the inferred number of contributors.


Subject(s)
DNA Fingerprinting/methods , DNA/genetics , Alleles , DNA/analysis , Gene Frequency , Humans , Likelihood Functions , Microsatellite Repeats , Monte Carlo Method , Polymerase Chain Reaction , Reproducibility of Results
SELECTION OF CITATIONS
SEARCH DETAIL